Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

25%

1 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
2(66.7%)
Phase 3
1(33.3%)
3Total
N/A(2)
Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT06107985Not ApplicableUnknown

To Develop and Validate a Structured Exercise Protocol and Its Efficacy in Sub Acromial Impingement Patients

Role: collaborator

NCT05531617Not ApplicableCompleted

A Prospective,Randomised, Open Label Study for Comparison of the Incidence and Severity of Postoperative Sore Throat (POST) Using C-MAC Video Laryngoscope and Traditional Macintosh Laryngoscope for Intubation

Role: lead

NCT03932500Unknown

Outcomes of Traumatic Brain Injury and External Validation of CRASH Prognostic Model

Role: lead

NCT00889525Phase 3Completed

Study of Cabergoline in Treatment of Corticotroph Pituitary Tumor

Role: lead

All 4 trials loaded